Matthew Shaw

Freeman Hospital

Papers

1

Total Citations

12

H-Index

1

About

Matthew Shaw is a leading urologic oncologist whose research centers on improving the diagnosis and risk stratification of prostate cancer. His major contributions lie in critically evaluating and advancing prostate biopsy techniques, particularly comparing the traditional transrectal approach with emerging alternatives to enhance diagnostic accuracy and patient safety. His highly cited 2022 work, "Prostate Cancer Diagnosis: Biopsy Approaches," has already garnered 12 citations, reflecting its immediate impact on clinical practice. Shaw is recognized for synthesizing complex evidence to guide clinicians toward more effective, less invasive biopsy strategies. Beyond this seminal paper, his broader body of work continues to shape the standard of care, helping to reduce the morbidity associated with prostate cancer diagnosis. For students and researchers, Shaw’s research offers a clear roadmap of how procedural innovation can directly translate into better patient outcomes in a rapidly evolving field.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Prostate Cancer Diagnosis: Biopsy Approaches
12 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Freeman Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago